AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
Kathy Jaworski, Maryam Ahmadian, Robin E Duncan, Eszter Sarkadi-Nagy, Krista A Varady, Marc K Hellerstein, Hui-Young Lee, Varman T Samuel, Gerald I Shulman, Kee-Hong Kim, Sarah de Val, Chulho Kang, Hei Sook Sul, Kathy Jaworski, Maryam Ahmadian, Robin E Duncan, Eszter Sarkadi-Nagy, Krista A Varady, Marc K Hellerstein, Hui-Young Lee, Varman T Samuel, Gerald I Shulman, Kee-Hong Kim, Sarah de Val, Chulho Kang, Hei Sook Sul
Abstract
A main function of white adipose tissue is to release fatty acids from stored triacylglycerol for other tissues to use as an energy source. Whereas endocrine regulation of lipolysis has been extensively studied, autocrine and paracrine regulation is not well understood. Here we describe the role of the newly identified major adipocyte phospholipase A(2), AdPLA (encoded by Pla2g16, also called HREV107), in the regulation of lipolysis and adiposity. AdPLA-null mice have a markedly higher rate of lipolysis owing to increased cyclic AMP levels arising from the marked reduction in the amount of adipose prostaglandin E(2) that binds the Galpha(i)-coupled receptor, EP3. AdPLA-null mice have markedly reduced adipose tissue mass and triglyceride content but normal adipogenesis. They also have higher energy expenditure with increased fatty acid oxidation within adipocytes. AdPLA-deficient ob/ob mice remain hyperphagic but lean, with increased energy expenditure, yet have ectopic triglyceride storage and insulin resistance. AdPLA is a major regulator of adipocyte lipolysis and is crucial for the development of obesity.
Figures
References
- Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007;27:79–101.
- Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78:783–809.
- Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1–G4.
- Dircks L SH. Acyltransferases of de novo glycerophospholipid biosynthesis. Prog Lipid Res. 1999;38:461–479.
- Yet SF LS, Hahm YT, Sul HS. Expression and identification of p90 as the murine mitochondrial glycerol-3-phosphate acyltransferase. J Biochem. 1993:9486–9491.
- Vance DE, Vance JE. Biochemistry of lipids, lipoproteins and membranes. 2002
- Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS. Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA) J Biol Chem. 2008;283:25428–25436.
- Schaloske RH, Dennis EA. The phospholipase A(2) superfamily and its group numbering system. Biochim Biophys Acta. 2006
- Yuan C, Rieke CJ, Rimon G, Wingerd BA, Smith WL. Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci U S A. 2006;103:6142–6147.
- Richelsen B. Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47:171–182.
- Aubert J, et al. Prostacyclin IP receptor up-regulates the early expression of C/EBPbeta and C/EBPdelta in preadipose cells. Mol Cell Endocrinol. 2000;160:149–156.
- Fajas L, Miard S, Briggs MR, Auwerx J. Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase. J Lipid Res. 2003;44:1652–1659.
- Forman BM, et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995;83:803–812.
- Yan H, Kermouni A, Abdel-Hafez M, Lau DC. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res. 2003;44:424–429.
- Cohen-Luria R RG. Prostaglandin E2 can bimodally inhibit and stimulate the epididymal adipocyte adenylyl cyclase activity. Cell signal. 1992;4:331–335.
- Kather H, Simon B. Biphasic effects of prostaglandin E2 on the human fat cell adenylate cyclase. J Clin Invest. 1979;64:609–612.
- Smas CM SH. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. 1993;73:725–734.
- Latasa MJ GM, Moon YS, Kang C, Sul HS. Occupancy and funtion of the −150 SRE and −65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Mol Cell Biol. 2003;23:5896–5907.
- Turner SM, et al. Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA. Am J Physiol Endocrinol Metab. 2003;285:E790–E803.
- Bell-Parikh LC, et al. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest. 2003;112:945–955.
- Reginato MJ, Krakow SL, Bailey ST, Lazar MA. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J Biol Chem. 1998;273:1855–1858.
- Vassaux G, Gaillard D, Ailhaud G, Negrel R. Prostacyclin is a specific effector of adipose cell differentiation. Its dual role as a cAMP- and Ca(2+)-elevating agent. J Biol Chem. 1992;267:11092–11097.
- Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507–520.
- Yoon M-J, et al. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisom proliferator-activated receptor. Diabetes. 2006;55:2562–2570.
- Johansson SM, Yang JN, Lindgren E, Fredholm BB. Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid. Acta Physiol. 2007;190:87–96.
- Fain JN, Leffler CW, Bahouth SW. Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. J Lipid Res. 2000;41:1689–1694.
- Girouard H, Savard R. The lack of bimodality in the effects of endogenous and exogenous prostaglandins on fat cell lipolysis in rats. Prostaglandins Other Lipid Mediat. 1998;56:43–52.
- Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273–2282.
- Gaillard D, Negrel R, Lagarde M, Ailhaud G. Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J. 1989;257:389–397.
- Massiera F, et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res. 2003;44:271–279.
- Petersen RK, et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res. 2003;44:2320–2330.
- Kopecky J, Hodny Z, Rossmeisl M, Syrovy I, Kozak LP. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am J Physiol. 1996;270:E768–E775.
- Hertzel AV, et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am J Physiol Endocrinol Metab. 2006;290:E814–E823.
- Lucas S, Tavernier G, Tiraby C, Mairal A, Langin D. Expression of human hormone-sensitive lipase in white adipose tissue of transgenic mice increases lipase activity but does not enhance in vitro lipolysis. J Lipid Res. 2003;44:154–163.
- Martinez-Botas J, et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 2000;26:474–479.
- Tansey JT, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 2001;98:6494–6499.
- Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;276:11252–11256.
- Viswanadha S, Londos C. Optimized conditions for measuring lipolysis in murine primary adipocytes. J Lipid Res. 2006;47:1859–1864.
- Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917.
- Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.
- Youn JH, Buchanan TA. Fasting does not impair inuslin-stimulated glucose uptake but alters intracellular glucose metabolism in conscious rats. Diabetes. 1993;42:757–763.
- Samuel VT, et al. Targeting foxo1 in mice using antisense oligonucleotides improves hepatic and peripheral insulin action. Diabetes. 2006;55:2042–2050.
- Lucas KK, Dennis EA. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 2005;77:235–248.
- Chen JL, et al. Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. J Biol Chem. 2005;280:25396–25402.
- Bansode RR, Huang W, Roy SK, Mehta M, Mehta KD. Protein kinase Cbeta deficiency increases fatty acid oxidation and reduces fat storage. J Biol Chem. 2008;283:231–236.
Source: PubMed